Dr Mark McGregor was awarded the Best New Concept Award at the meeting’s New Concepts Symposium for the concept titled:  ‘A phase II study of oncolytic immunotherapy of metastatic neuroendocrine tumours using intralesional rose Bengal diodium in combination with pembolizumab’.